Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | GHSR | Q92847 | 4/20 | 0.42 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | F7 | P08709 | 4/20 | 0.36 |
| ▸ | F3 | P13726 | 4/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 3/20 | 0.35 |
| ▸ | ACE | P12821 | 3/20 | 0.35 |
| ▸ | SRC | P12931 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7791803 | 0.94 | XIAP (0.44) | XIAPGHSRAGTR1F7F3 | |
| SCHEMBL8331115 | 0.89 | GHSR (0.46) | XIAPGHSRAGTR1F7F3 | |
| SCHEMBL7792142 | 0.89 | GHSR (0.55) | XIAPGHSRAGTR1F7F3 | |
| SCHEMBL7791878 | 0.88 | GHSR (0.49) | XIAPGHSRAGTR1F7F3 | |
| SCHEMBL7792105 | 0.87 | GHSR (0.55) | XIAPGHSRAGTR1 | |
| SCHEMBL7785909 | 0.87 | GHSR (0.48) | XIAPGHSRAGTR1F7F3 | |
| SCHEMBL7792158 | 0.86 | XIAP (0.45) | XIAPGHSRAGTR1F7F3 | |
| SCHEMBL7795969 | 0.85 | GHSR (0.57) | XIAPGHSRAGTR1F7F3 | |
| SCHEMBL7794660 | 0.85 | GHSR (0.56) | XIAPGHSRAGTR1F7F3 | |
| SCHEMBL7786108 | 0.85 | XIAP (0.47) | XIAPGHSRAGTR1F7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5968924-A | HAVE THE ABILITY TO STIMULATE THE RELEASE OF NATURAL OR ENDOGENOUS GROWTH HORMONE; TREATMENT OF OBESITY, OSTEOPOROSIS | MERCK & CO., INC. (US) | 1999-10-19 | — | — | US | claimed |
| EP-0659179-B1 | BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO INC (US) | 2001-11-21 | — | — | EP | disclosed |
| US-5968924-A | HAVE THE ABILITY TO STIMULATE THE RELEASE OF NATURAL OR ENDOGENOUS GROWTH HORMONE; TREATMENT OF OBESITY, OSTEOPOROSIS | MERCK & CO., INC. (US) | 1999-10-19 | — | — | US | disclosed |
| EP-0659179-A4 | BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE. | MERCK & CO INC (US) | 1995-08-09 | — | — | EP | disclosed |
| EP-0659179-A1 | BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO. INC. (US) | 1995-06-28 | — | — | EP | disclosed |
| WO-1994005634-A1 | BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO., INC. (US) | 1994-03-17 | — | — | WO | disclosed |